Relaxin/insulin-like family peptide receptor 4 (Rxfp4) expressing hypothalamic neurons modulate food intake and preference in mice

被引:12
|
作者
Lewis, Jo E. [1 ]
Woodward, Orla RM. [1 ]
Nuzzaci, Danae [1 ]
Smith, Christopher A. [1 ]
Adriaenssens, Alice E. [1 ]
Billing, Lawrence [1 ]
Brighton, Cheryl [1 ]
Phillips, Benjamin U. [2 ]
Tadross, John A. [1 ,3 ]
Kinston, Sarah J. [4 ]
Ciabatti, Ernesto [4 ]
Goettgens, Berthold [4 ]
Tripodi, Marco [5 ]
Hornigold, David [6 ]
Baker, David [6 ]
Gribble, Fiona M. [1 ]
Reimann, Frank [1 ]
机构
[1] Addenbrookes Hosp, Wellcome Trust MRC Inst Metab Sci Metab Res Labs, Hills Rd, Cambridge CB20QQ, England
[2] Univ Cambridge, Dept Physiol, Dev & Neurosci, Cambridge, England
[3] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[4] Univ Cambridge, Wellcome & MRC Cambridge Stem Cell Inst, Dept Haematol, Cambridge, England
[5] Neurobiol Div, MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England
[6] AstraZeneca Ltd, Res & Early Dev Cardiovasc, Renal & Metab CVRM, BioPharmaceut R&D, Cambridge, England
来源
MOLECULAR METABOLISM | 2022年 / 66卷
基金
英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
RXFP4; Insl5; CNS; VMH; Food intake; VENTROMEDIAL HYPOTHALAMUS; BODY-WEIGHT; FEEDING-BEHAVIOR; IN-VIVO; RELAXIN-3; ENERGY; NUCLEUS; INSL5; IDENTIFICATION; GPCR142;
D O I
10.1016/j.molmet.2022.101604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Insulin-like peptide 5 (INSL5) signalling, through its cognate receptor relaxin/insulin-like family peptide receptor 4 (RXFP4), has been reported to be orexigenic, and the high fat diet (HFD) preference observed in wildtype mice is altered in Rxfp4 knock-out mice. In this study, we used a new Rxfp4-Cre mouse model to investigate the mechanisms underlying these observations. Methods: We generated transgenic Rxfp4-Cre mice and investigated central expression of Rxfp4 by RT-qPCR, RNAscope and intraparenchymal infusion of INSL5. Rxfp4-expressing cells were chemogenetically manipulated in global Cre-reporter mice using designer receptors exclusively activated by designer drugs (DREADDs) or after stereotactic injection of a Cre-dependent AAV-DIO-Dq-DREADD targeting a population located in the ventromedial hypothalamus (RXFP4(VMH)). Food intake and feeding motivation were assessed in the presence and absence of a DREADD agonist. Rxfp4-expressing cells in the hypothalamus were characterised by single-cell RNA-sequencing (scRNAseq) and the connectivity of RXFP4(VMH) cells was investigated using viral tracing. Results: Rxfp4-Cre mice displayed Cre-reporter expression in the hypothalamus. Active expression of Rxfp4 in the adult mouse brain was confirmed by RT-qPCR and RNAscope. Functional receptor expression was supported by cyclic AMP-responses to INSL5 application in ex vivo brain slices and increased HFD and highly palatable liquid meal (HPM), but not chow, intake after intra-VMH INSL5 infusion. scRNAseq of hypothalamic RXFP4 neurons defined a cluster expressing VMH markers, alongside known appetite-modulating neuropeptide receptors (Mc4r, Cckar and Nmur2). Viral tracing demonstrated RXFP4(VMH) neural projections to nuclei implicated in hedonic feeding behaviour. Whole body chemogenetic inhibition (Di-DREADD) of Rxfp4-expressing cells, mimicking physiological INSL5-RXFP4 Gi-signalling, increased intake of the HFD and HPM, but not chow, whilst activation (Dq-DREADD), either at whole body level or specifically within the VMH, reduced HFD and HPM intake and motivation to work for the HPM. Conclusion: These findings identify RXFP4(VMH) neurons as regulators of food intake and preference, and hypothalamic RXFP4 signalling as a target for feeding behaviour manipulation. (C) 2022 The Authors. Published by Elsevier GmbH.
引用
收藏
页数:18
相关论文
共 44 条
  • [41] Exendin-4, a glucagon-like peptide 1 (GLP-1) receptor agonist, interacts with proteins and their products of digestion to suppress food intake in rats
    Aziz, A
    Anderson, GH
    FASEB JOURNAL, 2003, 17 (05): : A809 - A809
  • [42] Insulin-like growth factor binding protein-4 and-5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner
    Hermani, Alexander
    Shukla, Ashish
    Medunjanin, Senad
    Werner, Haim
    Mayer, Doris
    CELLULAR SIGNALLING, 2013, 25 (06) : 1395 - 1402
  • [43] Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multitargeted inhibitors targeting insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor tyrosine kinases
    Wang, Gary T.
    Mantel, Robert A.
    Hubbard, Robert D.
    Wilsbacher, Julie L.
    Zhang, Qian
    Tucker, Lora
    Hu, Xiaoming
    Kovar, Peter
    Johson, Erick F.
    Osterling, Donald J.
    Bouska, Jennifer
    Wang, Jieyi
    Bell, Randy L.
    Davidsen, Steven K.
    Sheppard, George S.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [44] Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases
    Wang, Gary T.
    Mantei, Robert A.
    Hubbard, Robert D.
    Wilsbacher, Julie L.
    Zhang, Qian
    Tucker, Lora
    Hu, Xiaoming
    Kovar, Peter
    Johnson, Eric F.
    Osterling, Donald J.
    Bouska, Jennifer
    Wang, Jieyi
    Davidsen, Steven K.
    Bell, Randy L.
    Sheppard, George S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (20) : 6067 - 6071